DuPont considers sale of nutrition and biosciences unit: Bloomberg

Dupont corporate headquarters in Wilmington, Delaware.
Getty Images

Industrial materials maker DuPont is considering a sale of its nutrition and biosciences unit, Bloomberg reported on Tuesday, citing people familiar with the matter.

The unit, which supplies everything from soy-based food ingredients to tablet binders, could be worth at least $20 billion as a standalone entity, Bloomberg said.

DuPont declined to comment on the unit's divestiture.

The Wilmington, Delaware-based company said in February that its overall goal was to divest about 10% of its portfolio.

DuPont was a part of DowDupont until a split earlier this year.

The nutrition and biosciences unit, DuPont's biggest revenue generator in 2018 on a pro-forma basis, was hit by lower sales of food, beverage and pharma solutions in the latest reported quarter, and brought in 4% lower sales than a year earlier.